FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134753603> ?p ?o ?g. }

• W3134753603 endingPage "e58" @default.
• W3134753603 startingPage "e56" @default.
• W3134753603 abstract "To reduce coronavirus disease 2019 (COVID-19) spread, federal agencies eased telemedicine restrictions including audio-only appointments. These changes permitted clinicians to prescribe buprenorphine to patients with opioid use disorder (OUD) without in-person or audio/video assessment. Our clinic utilized existing community collaborations to implement protocols and extend outreach. We describe 3 patients with OUD who engaged with treatment through outreach with trusted community partners and low-threshold telemedicine.Patient 1-a 40-year-old man with severe OUD who injected heroin and was living outside. A weekend harm reduction organization volunteer the patient previously knew used her mobile phone to facilitate an audio-only intake appointment during clinic hours. He completed outpatient buprenorphine initiation. Patient 2-a 48-year-old man with severe opioid and methamphetamine use disorders who injected both and was living in his recreational vehicle. He engaged regularly with syringe services program (SSP), but utilized no other healthcare services. Initially, an SSP worker connected him to our clinic for audio-only appointment using their landline to initiate buprenorphine; a harm reduction volunteer coordinated follow-up. Patient 3-a 66-year-old man with moderate OUD used non-prescribed pill opioids without prior buprenorphine experience. He lived over 5 hours away in a rural town. He underwent virtual appointment and completed home buprenorphine initiation.These 3 cases illustrate examples of how policy changes allowing for telemedicine buprenorphine prescribing can expand availability of addiction services for patients with OUD who were previously disengaged for reasons including geography, lack of housing, transportation difficulties, and mistrust of traditional healthcare systems." @default.
• W3134753603 created "2021-03-15" @default.
• W3134753603 creator A5027310994 @default.
• W3134753603 creator A5039302741 @default.
• W3134753603 creator A5044455111 @default.
• W3134753603 creator A5046610774 @default.
• W3134753603 creator A5051529035 @default.
• W3134753603 creator A5063877463 @default.
• W3134753603 creator A5078623450 @default.
• W3134753603 creator A5087115421 @default.
• W3134753603 date "2021-02-19" @default.
• W3134753603 modified "2023-10-10" @default.
• W3134753603 title "Low-Threshold Buprenorphine via Community Partnerships and Telemedicine—Case Reports of Expanding Access to Addiction Treatment During COVID-19" @default.
• W3134753603 cites W2093699898 @default.
• W3134753603 cites W2109770916 @default.
• W3134753603 cites W2566331999 @default.
• W3134753603 cites W2887228441 @default.
• W3134753603 cites W2897839280 @default.
• W3134753603 cites W2977651311 @default.
• W3134753603 cites W3003465021 @default.
• W3134753603 cites W3014703200 @default.
• W3134753603 cites W3014861007 @default.
• W3134753603 cites W3014862161 @default.
• W3134753603 cites W3025082979 @default.
• W3134753603 cites W3026866789 @default.
• W3134753603 cites W3028030324 @default.
• W3134753603 cites W3057931473 @default.
• W3134753603 doi "https://doi.org/10.1097/adm.0000000000000811" @default.
• W3134753603 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34374502" @default.
• W3134753603 hasPublicationYear "2021" @default.
• W3134753603 type Work @default.
• W3134753603 sameAs 3134753603 @default.
• W3134753603 citedByCount "8" @default.
• W3134753603 countsByYear W31347536032021 @default.
• W3134753603 countsByYear W31347536032022 @default.
• W3134753603 countsByYear W31347536032023 @default.
• W3134753603 crossrefType "journal-article" @default.
• W3134753603 hasAuthorship W3134753603A5027310994 @default.
• W3134753603 hasAuthorship W3134753603A5039302741 @default.
• W3134753603 hasAuthorship W3134753603A5044455111 @default.
• W3134753603 hasAuthorship W3134753603A5046610774 @default.
• W3134753603 hasAuthorship W3134753603A5051529035 @default.
• W3134753603 hasAuthorship W3134753603A5063877463 @default.
• W3134753603 hasAuthorship W3134753603A5078623450 @default.
• W3134753603 hasAuthorship W3134753603A5087115421 @default.
• W3134753603 hasBestOaLocation W31347536031 @default.
• W3134753603 hasConcept C118552586 @default.
• W3134753603 hasConcept C126322002 @default.
• W3134753603 hasConcept C138816342 @default.
• W3134753603 hasConcept C159110408 @default.
• W3134753603 hasConcept C160735492 @default.
• W3134753603 hasConcept C162324750 @default.
• W3134753603 hasConcept C170493617 @default.
• W3134753603 hasConcept C17744445 @default.
• W3134753603 hasConcept C199539241 @default.
• W3134753603 hasConcept C2776716344 @default.
• W3134753603 hasConcept C2778949969 @default.
• W3134753603 hasConcept C2779418921 @default.
• W3134753603 hasConcept C2779891985 @default.
• W3134753603 hasConcept C2781063702 @default.
• W3134753603 hasConcept C2781400479 @default.
• W3134753603 hasConcept C48856860 @default.
• W3134753603 hasConcept C50522688 @default.
• W3134753603 hasConcept C512399662 @default.
• W3134753603 hasConcept C529928208 @default.
• W3134753603 hasConcept C545542383 @default.
• W3134753603 hasConcept C71924100 @default.
• W3134753603 hasConceptScore W3134753603C118552586 @default.
• W3134753603 hasConceptScore W3134753603C126322002 @default.
• W3134753603 hasConceptScore W3134753603C138816342 @default.
• W3134753603 hasConceptScore W3134753603C159110408 @default.
• W3134753603 hasConceptScore W3134753603C160735492 @default.
• W3134753603 hasConceptScore W3134753603C162324750 @default.
• W3134753603 hasConceptScore W3134753603C170493617 @default.
• W3134753603 hasConceptScore W3134753603C17744445 @default.
• W3134753603 hasConceptScore W3134753603C199539241 @default.
• W3134753603 hasConceptScore W3134753603C2776716344 @default.
• W3134753603 hasConceptScore W3134753603C2778949969 @default.
• W3134753603 hasConceptScore W3134753603C2779418921 @default.
• W3134753603 hasConceptScore W3134753603C2779891985 @default.
• W3134753603 hasConceptScore W3134753603C2781063702 @default.
• W3134753603 hasConceptScore W3134753603C2781400479 @default.
• W3134753603 hasConceptScore W3134753603C48856860 @default.
• W3134753603 hasConceptScore W3134753603C50522688 @default.
• W3134753603 hasConceptScore W3134753603C512399662 @default.
• W3134753603 hasConceptScore W3134753603C529928208 @default.
• W3134753603 hasConceptScore W3134753603C545542383 @default.
• W3134753603 hasConceptScore W3134753603C71924100 @default.
• W3134753603 hasIssue "1" @default.
• W3134753603 hasLocation W31347536031 @default.
• W3134753603 hasLocation W31347536032 @default.
• W3134753603 hasLocation W31347536033 @default.
• W3134753603 hasLocation W31347536034 @default.
• W3134753603 hasOpenAccess W3134753603 @default.
• W3134753603 hasPrimaryLocation W31347536031 @default.
• W3134753603 hasRelatedWork W2043449521 @default.
• W3134753603 hasRelatedWork W2898142040 @default.
• W3134753603 hasRelatedWork W2907334930 @default.

• next